CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection	2012-10-12	Registered
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study)	2013-01-17	Registered
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study)	2013-01-18	Registered
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study)	2013-01-18	Registered
Safety with interferon in skin carcinomas (SCIENCE study)	2013-01-30	Registered
Squamous cell carcinoma interferons (CECIN study)	2013-02-01	Registered
Interferon Combination in basal cell carcinoma (InCarbacel-V study)	2013-02-01	Registered
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers	2013-02-08	Registered
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study)	2013-05-16	Registered
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study)	2013-06-06	Registered
Safety and pharmacokinetics of CIGB-552	22/05/2015	Registered
VIDA study	22/06/2020	Registered outdated
Interferon Combination in basal cell carcinoma (InCarbacel-IV study)	22/08/2013	Registered
DENIS Study	22/10/2018	Registered outdated
EGF in bilateral symmetric diabetic neuropathy	23/03/2020	Registered outdated
CIGB-500 in acute myocardial infarction (AMIGOS study)	23/04/2014	Registered
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III	24/04/2023	Registered
ESAR-814 Study	26/01/2017	Registered
VISION Study	26/10/2021	Registered
ABDALA Clinical Study	26/11/2020	Registered outdated

Registered Trials

Registration process

CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

About the RPCEC

Useful resources